Tauriga Sciences Inc. Appoints Robert Millman, JD as a Member of the Company's Business Advisory Board
May 05, 2014 10:28 ET
|
Tauriga Sciences Inc
NEW YORK, May 5, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with a pending acquisition in the cannabis space,...
Tauriga Sciences Inc. Appoints Dr. Lawrence A. May, M.D., F.A.C.P., to the Position of Chief Medical Officer Effective Immediately
April 28, 2014 08:33 ET
|
Tauriga Sciences Inc
LOS ANGELES, April 28, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with a pending acquisition in the cannabis...
Tauriga Sciences Inc. Aggregate Private Placement Proceeds Exceed $1,100,000 USD Priced at 6 Cents Per Share
April 23, 2014 16:37 ET
|
Tauriga Sciences Inc
NEW YORK, April 23, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the "Company"), a diversified life sciences company with key assets that include active license...
Tauriga Sciences Inc. Appoints General Ronald R. Fogleman, USAF, Retired, as a Member of the Company's Business Advisory Board
April 15, 2014 06:20 ET
|
Tauriga Sciences Inc
NEW YORK, April 15, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include active license...
Tauriga Sciences Inc. Updates Its Upcoming Investor Conference and Presentation Schedule Through July 2014
April 03, 2014 07:39 ET
|
Tauriga Sciences Inc
NEW YORK, April 3, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include active license...
Tauriga Sciences Inc. Fully Repays and Retires the Convertible Note Held by Group 10 Holdings LLC for Principal Amount of $157,500 USD
March 31, 2014 11:40 ET
|
Tauriga Sciences Inc
MIAMI, March 31, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include active license...
Tauriga Sciences Inc. Completes $800,000 USD Equity Private Placement Priced at 6 Cents per Share
March 31, 2014 06:15 ET
|
Tauriga Sciences Inc
NEW YORK, March 31, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include active license...
Tauriga Sciences Inc. Launches $1,700,000 USD Commercial Pilot Test With the EPA and the Metropolitan Sewer District of Greater Cincinnati
March 26, 2014 15:02 ET
|
Tauriga Sciences Inc
CINCINNATI, March 26, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include license agreements...
Tauriga Sciences Inc. Fully Retires the Secured Convertible Promissory Note Held by Typenex Co-Investment, LLC for Original Principal Amount of $555,000 USD
March 24, 2014 03:05 ET
|
Tauriga Sciences Inc
LOS ANGELES, March 24, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include license agreements,...
Tauriga Sciences Inc. Showcases Its Acquisition of Revenue Generating California Based Developer of Topical and Medicinal Cannabis Creams
March 21, 2014 01:25 ET
|
Tauriga Sciences Inc
OAKLAND, Calif., March 21, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include license...